Works matching IS 10792082 AND DT 2022 AND VI 79 AND IP 24


Results: 16
    1
    2
    3
    4
    5
    6
    7

    impact of COVID-19 monoclonal antibodies on clinical outcomes: A retrospective cohort study.

    Published in:
    American Journal of Health-System Pharmacy, 2022, v. 79, n. 24, p. 2222, doi. 10.1093/ajhp/zxac295
    By:
    • Nagler, Arielle R.;
    • Horwitz, Leora I;
    • Jones, Simon;
    • Petrilli, Christopher M;
    • Iturrate, Eduardo;
    • Lighter, Jennifer L;
    • Phillips, Michael;
    • Bosworth, Brian P;
    • Polsky, Bruce;
    • Volpicelli, Frank M;
    • Dapkins, Isaac;
    • Viswanathan, Anand;
    • François, Fritz;
    • Kalkut, Gary
    Publication type:
    Article
    8
    9

    Olipudase Alfa-rpcp.

    Published in:
    American Journal of Health-System Pharmacy, 2022, v. 79, n. 24, p. 2200, doi. 10.1093/ajhp/zxac273
    Publication type:
    Article
    10
    11

    Ibrexafungerp: A new triterpenoid antifungal.

    Published in:
    American Journal of Health-System Pharmacy, 2022, v. 79, n. 24, p. 2208, doi. 10.1093/ajhp/zxac256
    By:
    • Sucher, Allana J;
    • Thai, Annie;
    • Tran, Charlene;
    • Mantena, Netra;
    • Noronha, Allwyn;
    • Chahine, Elias B
    Publication type:
    Article
    12
    13
    14
    15

    ASHP Guidelines on Preventing Diversion of Controlled Substances.

    Published in:
    American Journal of Health-System Pharmacy, 2022, v. 79, n. 24, p. 2279, doi. 10.1093/ajhp/zxac246
    By:
    • Clark, John;
    • Fera, Toni;
    • Fortier, Christopher;
    • Gullickson, Kristine;
    • Hays, Amanda;
    • Murdaugh, Lee;
    • Ogden, Ricky;
    • O'Neal, Brian;
    • Rush, Jordan;
    • Vest, Tyler
    Publication type:
    Article
    16